| ID | 117185 |
| 著者 |
Okada, Masaki
Sakamoto Hospital
板東, 浩
Sakamoto Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association
KAKEN研究者をさがす
Iwatsuki, Noboru
Sakamoto Hospital
Sakamoto, Kazuki
Sakamoto Hospital
Ogawa, Tomoya
Sakamoto Hospital
|
| キーワード | Imeglimin
Twymeeg
Duloxetine Hydrochloride
Cymbalta
Type 2 Diabetes
Depression
Mild Cognitive Impairment
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | Background: Imeglimin (Twymeeg) has been effective for patients with type 2 diabetes (T2D).
Case Presentation: The patient is an 82-year-old female with T2D, arthralgia, and depression. Results: She was given duloxetine hydrochloride (Cymbalta) and Twymeeg, leading to improved symptoms of low back pain (LBP), knee osteoarthritis, osteoporosis, depression, and possible mild cognitive impairment (MCI). HbA1c decreased from 8.8% to 7.1% for 4 months with a single administration of Twymeeg 2000mg/day. Discussion: In recent clinical practice, elderly cases often tend to have simultaneously these problems, which are medical and social crucial problems. Twymeeg and Cymbalta may be indispensable agents for future practice. |
| 掲載誌名 |
Diabetes Research : Open Access
|
| 出版者 | Asploro
|
| 巻 | 4
|
| 号 | 1
|
| 開始ページ | 1
|
| 終了ページ | 7
|
| 発行日 | 2022-06-06
|
| 権利情報 | This is an open-access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
|
